Evidence map›Paper›PMID 24777587›Full record

ArticleLung2014

Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.

Seref Kul, Hatice Kutbay Ozcelik, Huseyin Uyarel, Gultekin Karakus, Tolga Sinan Guvenc, Murat Yalcınsoy, Emin Asoglu, Ahu Sarbay Kemik, Abdurrahman Tasal, Sinem Gungor and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Lung, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Advanced imaging of cardiac sarcoidosis.Current cardiology reports · 2015
    Review
  13. Article
  14. The Role of Serum Galectin-3 Levels in Patients with Sarcoidosis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Seref KulDepartment of Cardiology, Faculty of Medicine, Bezmialem Vakif University, Adnan Menderes Bulvarı (Vatan cad.), Fatih, 34093, Istanbul, Turkey, doktorseref@hotmail.com.
Hatice Kutbay Ozcelik
Huseyin Uyarel
Gultekin Karakus
Tolga Sinan Guvenc
Murat Yalcınsoy
Emin Asoglu
Ahu Sarbay Kemik
Abdurrahman Tasal
Sinem Gungor
Ercan Karaarslan
Levent Kart
Omer Goktekin
Bezmiâlem Vakıf Üniversitesi · TRAcıbadem University · TRIstanbul University · TRKafkas University · TRYedikule Teaching Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac involvement in sarcoidosis has been associated with poor prognosis. We evaluated myocardial contractility quantitatively in a cohort of pulmonary sarcoidosis (PS) patients with and without cardiac involvement. We also studied markers of fibrosis (tenascin-C [Tn-C] and galectin-3 [Gl-3]) as diagnostic tools for PS and cardiac sarcoidosis (CS).

methodsForty ambulatory patients with PS of grades 1-2 and 26 healthy subjects were prospectively enrolled. All patients with PS underwent cardiac magnetic resonance (CMR) to explore the presence of CS. The study population was divided into three groups: controls (n = 26), non-CS patients (n = 34), and CS patients (n = 6). Speckle-tracking strain echocardiography (STE) was performed on all patients, and Gl-3 and Tn-C values were measured in all patients and controls.

resultsPS patients had higher levels of Gl-3 and Tn-C than did controls, and the STE parameters of PS patients, including global longitudinal strain (GLS) and global circumferential strain (GCS), were lower than those of controls (p < 0.001 for all comparisons). GLS values were lower in CS patients than in the other groups (p = 0.05).

conclusionsPS patients demonstrate reduced cardiac contractility, independent of CMR-proven structural cardiac lesions, while patients with structural lesions have a more pronounced drop in strain parameters. Tn-C and Gl-3 are promising markers for the diagnosis of PS, but they are not specific for cardiac involvement.

Indexed as

Echocardiography, DopplerEchocardiography, Three-DimensionalMyocardial ContractionAdultBiomarkersBlood ProteinsCardiomyopathiesCase-Control StudiesFeasibility StudiesFemaleFibrosisGalectin 3GalectinsHumansMagnetic Resonance Imaging, CineMaleBiomarkersBlood ProteinsGalectin 3GalectinsLGALS3 protein, humanTenascin

Identifiers

PMID24777587
OpenAlexW1976510732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.